ClearNote Health's enhanced Avantect Pancreatic Cancer Test features industry-leading detection sensitivity and specificity ...

Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...

Studies published by 20/20 Biolabs and several independent research groups in the U.S. and Asia over the past 10 months add to the growing body of evidence that our company’s patented multi-cancer ...

What if people could detect cancer and other diseases with the same speed and ease of a pregnancy test or blood glucose meter? Researchers at the Carl R. Woese Institute for Genomic Biology are a step ...

A machine learning-driven eNose detects ovarian cancer in blood plasma with 97 % sensitivity and specificity, offering a promising biomarker-agnostic approach.

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced four strategic additions to its executive leadership team: Jeff ...

This predictive model built on readily acquired clinical data provides encouraging results for the detection of residual disease. External validation and prospective studies implementing the model in ...

Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...